World's Best Scientists 2026 revealed!
Gunnar B. Kristensen

Gunnar B. Kristensen

D-Index & Metrics

Medicine

D-Index
83
Citations
30475
World Ranking
15458
National Ranking
72

Overview

Gunnar B. Kristensen is affiliated with Oslo University Hospital in Norway and has contributed extensively to the field of medicine with a focus on reproductive health and oncology. Their academic work spans several subfields including reproductive medicine, obstetrics and gynecology, radiology, nuclear medicine and imaging, pulmonary and respiratory medicine, and oncology.

Their research is centered around key topics such as endometrial and cervical cancer treatments, ovarian cancer diagnosis and treatment, MRI in cancer diagnosis, endometriosis research and treatment, radiomics and machine learning in medical imaging, renal cell carcinoma treatment, and the interplay between cancer, hypoxia, and metabolism.

Recent publications by Kristensen include:

  • MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum (2020, Journal of Clinical Oncology)
  • Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification (2021, Cancers)
  • Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994 (2023, Journal of Clinical Oncology)
  • Assessment of Progression-Free Survival as a Surrogate End Point of Overall Survival in First-Line Treatment of Ovarian Cancer (2020, JAMA Network Open)
  • MRI Distinguishes Tumor Hypoxia Levels of Different Prognostic and Biological Significance in Cervical Cancer (2020, Cancer Research)

Kristensen's frequent co-authors reflect collaborative work within the medical research community and include:

  • Kristina Lindemann
  • Hanne A. Askautrud
  • Andreas Kleppe
  • Wanja Kildal
  • Manohar Pradhan

Key publication venues for their research output are:

  • International Journal of Gynecological Cancer
  • Journal of Clinical Oncology
  • Cancers
  • Gynecologic Oncology
  • European Journal of Cancer

Kristensen's body of work heavily emphasizes cancer diagnosis and treatment strategies, particularly those related to gynecological cancers. Their contributions include studies leveraging advanced imaging techniques such as MRI to assess tumor characteristics and treatment response, as well as exploring molecular classifications and biomarkers for risk stratification.

Their research output includes 73 publications in medicine with a particular impact in reproductive medicine and oncology, addressing both clinical treatment approaches and diagnostic technologies.

Best Publications

  • Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

    Ignace Vergote;Claes G. Tropé;Frédéric Amant;Gunnar B. Kristensen

  • A phase 3 trial of bevacizumab in ovarian cancer.

    Timothy J Perren;Ann Marie Swart;Jacobus Pfisterer;Jonathan A Ledermann

  • Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial

    Eric Pujade-Lauraine;Felix Hilpert;Beatrice Weber;Alexander Reuss

  • Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.

    MK Parmar;JA Ledermann;N Colombo;Bois A Du

  • Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.

    Amit M. Oza;Adrian D. Cook;Jacobus Pfisterer;Andrew Embleton

  • Gene Expression Programs in Response to Hypoxia: Cell Type Specificity and Prognostic Significance in Human Cancers

    Jen Tsan Chi;Jen Tsan Chi;Zhen Wang;Dimitry S.A. Nuyten;Edwin H. Rodriguez

  • Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial.

    Gordon J.S. Rustin;Maria E.L. Van Der Burg;Clare L. Griffin;David Guthrie

  • Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse

    Eric Pujade-Lauraine;Uwe Wagner;Elisabeth Aavall-Lundqvist;Val Gebski

  • Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG).

    Gordon John Sampson Rustin;Ignace Vergote;Elizabeth Eisenhauer;Eric Pujade-Lauraine

  • 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004).

    A du Bois;M Quinn;T Thigpen;J Vermorken

  • Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer - Results from two randomised studies

    Thomas Hogberg;Mauro Signorelli;Carlos Freire de Oliveira;Roldano Fossati

  • Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients

    Vera M Abeler;Odd Røyne;Steinar Thoresen;Håvard E Danielsen

  • Gene Expression Patterns in Ovarian Carcinomas

    Marci E. Schaner;Douglas T. Ross;Giuseppe Ciaravino;Therese Sørlie

  • Use of multiple PCR primer sets for optimal detection of human papillomavirus.

    Frank Karlsen;Mina Kalantari;Andy Jenkins;Erik Pettersen

  • The Prognostic Significance of Residual Disease, FIGO Substage, Tumor Histology, and Grade in Patients with FIGO Stage III Ovarian Cancer

    Amin Ph. Makar;Mark Baekelandt;Claes O. Tropé;Gunnar B. Kristensen

  • Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer Intergroup.

    I Vergote;G J Rustin;E A Eisenhauer;G B Kristensen

  • Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials.

    I Vergote;C Coens;M Nankivell;G B Kristensen

  • Tumor Size, Depth of Invasion, and Grading of the Invasive Tumor Front Are the Main Prognostic Factors in Early Squamous Cell Cervical Carcinoma

    Gunnar B. Kristensen;Vera M. Abeler;Bjørn Risberg;Claes Tropé

  • Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers

    Åslaug Helland;Michael S. Anglesio;Michael S. Anglesio;Joshy George;Joshy George;Prue A. Cowin

  • Carcinoma of the fallopian tube.

    Mark Baekelandt;Anne Jorunn Nesbakken;Gunnar B. Kristensen;Claes G. Tropé

Frequent Co-Authors

Claes G. Tropé
Claes G. Tropé University of Oslo
Jahn M. Nesland
Jahn M. Nesland Oslo University Hospital
Ben Davidson
Ben Davidson Oslo University Hospital
Anne Lise Børresen-Dale
Anne Lise Børresen-Dale Oslo University Hospital
Sandro Pignata
Sandro Pignata National Cancer Institute
Andreas du Bois
Andreas du Bois Johannes Gutenberg University of Mainz
Val Gebski
Val Gebski University of Sydney
Jonathan A. Ledermann
Jonathan A. Ledermann University College London
Iris Goldberg
Iris Goldberg Sheba Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine doesn’t always require a traditional MD path. There are various online msn pmhnp programs available for those interested in mental health care. These programs prepare nurses for advanced roles in psychiatric care and can often be completed in an accelerated format.

For students interested in the administrative side of healthcare, a health care administration degree online provides a flexible way to build vital leadership and management skills. These degrees open doors to in-demand roles in hospitals, clinics, and healthcare organizations.

Cost is always a consideration. Exploring options for the mha degree cost can help you find affordable master’s programs in healthcare administration, allowing you to advance your career without taking on excessive debt.

For those aiming even higher, you might consider cheap dnp online programs to reach the highest clinical levels in nursing. These programs are designed for working professionals seeking flexibility and affordability.

Online degrees make it easier than ever to pursue these rewarding healthcare pathways, whether your passion lies in direct patient care, mental health, or healthcare leadership.

Best Scientists Citing Gunnar B. Kristensen

Trending Scientists

Recently Published Articles